A Preliminary Report
積少成多試管嬰兒:高齡不孕、卵巢功能低下的求子新策略(初步報告)
蔡鋒博,陳昭雯,林昭彰,張月嬌,陳曉青,徐慧鈴,潘孟麗,張琇媛,施俐君 博元婦產科,不孕症試管嬰兒中心
Feng-Po Tsai,Chao-Wen Chen,Chao-chang Lin,Yueh-Chiao Chang,Hsiao-Ching Chen,Hui-Ling Hsu,Meng-LI Pan,Hsiu-Yuan Chang,Li-Chun Shr Poyuan Women clinic,IVF centre,Chawghua Taiwan
Introduction:
Low responders (LR) to ovarian stimulation represent a substantial proportion of the patients enrolled in assisted reproduction programmes. The setbacks of LR are the number of oocytes retrieved and suboptimal oocyte maturation, embryo quality and cycle/transfer cancellation rates with respect to age-matched normoresponders.
Materials and methods:
A total of 5 LR patients, defined as women in whom less than 5 oocytes were retrieved in a single ovarian stimulation , were prospectively included in the study. 5 patients were selected after evaluating their ovarian function.
All 5 patients who met the criteria of having a FSH concentration >11IU/ml on cycle day 3 and an antral follicle (2–10mm during early follicular phase) count <6 among both ovaries were considered eligible for the study. Additionally, anti-Müllerian hormone blood concentrations <1pmol/l were also considered as an inclusion criteria .
After ovarian stimulation and oocyte retrieval , mature oocytes were inseminated . The embryos if any were frozen and stored for use in a subsequent cycle. The procedure was repeated in two or more stimulation cycles and met the need for a total number of 3 or 4 embryos to be transferred in a consecutive cycle a standard situation for a normoresponders.
Result:
All 5 LR patients got pregnant successfully . One patient had a twin pregnancy and four were singleton.
Conclusion:
Even though single embryo transfer is considered as an effective means of reducing multiple pregnancy, single embryo transfer may not be the preferred choice for all patients undergoing IVF/ICSI. Since the chance per embryo declines with advancing female age, increasing number of transferred embryo can compensate for this declining chance.
Accumulation of embryos by vitrification and simultaneous transfer represents a successful alternative for Low Responder patients, yielding comparable success rates to those in normoresponders and avoiding adverse effects of a low response.